Devil's Claw (Harpagophytum procumbens)

Joint painAnti-inflammatory

A Southern African desert plant whose root extract is well-studied for back and joint pain. Comparable to mild NSAIDs in some trials.

EvidenceModerate

Moderate for osteoarthritis, lower back pain, and tendonitis. Multiple positive RCTs; comparable to slow-onset NSAIDs. Effects: 4–8 weeks.

Harpagophytum procumbens (named for the hooked claws on its fruit) is native to the Kalahari. Its harpagoside-rich root has been used by San and Khoi peoples for inflammation and pain. Modern German clinical use and trials support meaningful pain relief in osteoarthritis, lower back pain, and tendonitis — often comparable to mild NSAIDs (and gentler on the gut). Slower-acting than NSAIDs; build up over weeks.

Form
Standardised devil's claw extract to ≥50 mg harpagoside per dose.
Dose
1,000–2,000 mg/day extract, or 50–100 mg harpagoside daily, split.
Timing
With food.
Schedule
Daily.
Side effects
GI upset, diarrhea, headache. Generally well-tolerated.
Interactions
Anticoagulants — mild additive blood-thinning. Diabetes medications — additive glucose lowering. P-gp / CYP substrates — possible mild interactions.
Contraindications
Active peptic ulcer (devil's claw increases stomach acid). Gallstones (bile-flow effects). Pregnancy. Cardiac arrhythmia (case reports).
Lab markers
Not standard.
Food sources
Not in everyday food.

Pairs with

Curcumin, boswellia, omega-3 (joint pain stack).